/ Resources / Nanomaterial Resources / Ask the Experts: Considerations for Nanoparticle Therapeutics

Ask the Experts: Considerations for Nanoparticle Therapeutics

Join a panel of experts as they discuss nanoparticle technology and key considerations for nanoparticle-based drug delivery.

From the latest mRNA vaccines to drug delivery systems, nanoparticles are increasingly popular therapeutic tools. Nanoparticles are versatile nano-sized vessels that shuttle small-molecule drugs, peptides, proteins, and nucleic acids to targeted sites in the body. For many scientists, how to leverage this cutting-edge technology remains a mystery. In this roundtable discussion, a panel of experts will discuss key considerations for manufacturing nanoparticle therapeutics.

Custom Nanobody Discovery Services

Topics to be covered:

  • The nanoparticle manufacturing pipeline
  • Nanoparticle types and utilities
  • Regulatory and GMP considerations
  • Scaling up nanoparticle production

Robert Proul

Robert Proulx

President and CEO of Imagion Biosystems

Tom Darlington

Tom Darlington, Ph.D.

VP Operations & Quality at Fortis Life Sciences

Rondii Lynberg

Rondii Lynberg

Director of Quality Assurance & Regulatory Compliance at Fortis Life Sciences